E
E B Nelson
Researcher at United States Military Academy
Publications - 4
Citations - 370
E B Nelson is an academic researcher from United States Military Academy. The author has contributed to research in topics: Losartan & Angiotensin II. The author has an hindex of 4, co-authored 4 publications receiving 369 citations. Previous affiliations of E B Nelson include University of California, Irvine.
Papers
More filters
Journal ArticleDOI
Effects of modulators of the renin-angiotensin-aldosterone system on cough. Losartan Cough Study Group.
Yves Lacourcière,Hans R. Brunner,Richard S. Irwin,Bengt E. Karlberg,Lawrence E. Ramsay,D B Snavely,Tom Dobbins,Elizabeth P. Faison,E B Nelson +8 more
TL;DR: The incidence of cough related to the type 1 Ang II receptor antagonist losartan is significantly lower than that observed with lisinopril, and similar to that seen with hydrochlorothiazide in patients with a rechallenged ACE inhibitor cough.
Journal ArticleDOI
Blood pressure effects of the angiotensin II receptor blocker, losartan.
Michael A. Weber,R L Byyny,J H Pratt,Elizabeth P. Faison,D B Snavely,Allan I. Goldberg,E B Nelson +6 more
TL;DR: Ambulatory blood pressure monitoring, which virtually eliminated antihypertensive placebo responses, demonstrated clear 24-hour efficacy for losartan, 50mg once daily, as well as for higher doses of 100 mg once daily and 50 mg twice daily.
Journal Article
Association between cough and angiotensin converting enzyme inhibitors versus angiotensin II antagonists: the design of a prospective, controlled study.
TL;DR: It is expected that the new class of antihypertensive agents, angiotensin II antagonists, will not beassociated with the high incidence of dry cough associated with the use of ACE inhibitors.
Journal ArticleDOI
Extended‐release felodipine in patients with mild to moderate hypertension
Michael A. Weber,Allan I. Goldberg,Allan I. Goldberg,Elizabeth P. Faison,Elizabeth P. Faison,Katherine Lipschutz,Katherine Lipschutz,David A Shapiro,David A Shapiro,E B Nelson,E B Nelson,John D. Irvin,John D. Irvin +12 more
TL;DR: The 24‐hour efficacy of felodipine was confirmed, and much of the peak antihypertensive effect was still present at trough, confirming the 24‐week efficacy of the drug.